From 2013 to 2023, the mortality rate from cerebrovascular diseases in Australia showed a consistent downward trend, decreasing from 45.6 to 35.5 deaths per hundred thousand persons. There was a notable drop of 5.04% in 2016, and the year 2020 saw the most significant year-on-year decrease at 5.63%. The compound annual growth rate (CAGR) over the past 5 years has been approximately -2.36%.
Forecast data from 2024 to 2028 indicate a continuation in the decline with an average annual CAGR of -1.42%, culminating in a projected rate of 32.4 by 2028, reflecting an overall reduction of 6.9% over the five-year forecast period.
Future trends to watch for:
- Continued advancements in medical technology and healthcare management.
- Implementation of effective public health campaigns focused on stroke prevention.
- Growing awareness and adherence to healthier lifestyles and preventive care measures.
- Potential impacts of aging population and chronic disease prevalence.
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...